Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6599 USD | +8.18% | +1.52% | -29.04% |
Feb. 13 | SunLink Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
Feb. 12 | North American Morning Briefing : Stock Futures -2- | DJ |
Valuation
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 9.568 | 10.27 | 6.175 | 23.67 | 6.956 | 6.399 |
Enterprise Value (EV) 1 | 9.17 | 5.492 | -0.6791 | 18.04 | 1.425 | 2.996 |
P/E ratio | -6.6 x | -5.97 x | -5.46 x | 3.48 x | -3.43 x | -3.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.18 x | 0.23 x | 0.13 x | 0.58 x | 0.17 x | 0.13 x |
EV / Revenue | 0.18 x | 0.12 x | -0.01 x | 0.44 x | 0.03 x | 0.06 x |
EV / EBITDA | -67.4 x | -12 x | -0.61 x | 5.58 x | -0.19 x | -5.38 x |
EV / FCF | -14,672 x | 8.36 x | -0.16 x | -2.69 x | -0.34 x | -1.31 x |
FCF Yield | -0.01% | 12% | -636% | -37.2% | -297% | -76.5% |
Price to Book | 0.55 x | 0.68 x | 0.45 x | 1.14 x | 0.36 x | 0.37 x |
Nbr of stocks (in thousands) | 7,417 | 6,987 | 6,899 | 6,920 | 6,954 | 7,032 |
Reference price 2 | 1.290 | 1.470 | 0.8950 | 3.420 | 1.000 | 0.9100 |
Announcement Date | 9/25/18 | 9/27/19 | 9/29/20 | 9/27/21 | 9/28/22 | 9/28/23 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 52.17 | 45.62 | 47.81 | 40.68 | 41.34 | 47.95 |
EBITDA 1 | -0.136 | -0.457 | 1.121 | 3.232 | -7.383 | -0.557 |
EBIT 1 | -1.994 | -2.185 | -0.329 | 1.871 | -8.926 | -2.322 |
Operating Margin | -3.82% | -4.79% | -0.69% | 4.6% | -21.59% | -4.84% |
Earnings before Tax (EBT) 1 | -1.478 | -2.078 | -0.29 | 7 | -1.615 | -1.662 |
Net income 1 | -1.593 | -1.754 | -1.14 | 6.89 | -2.009 | -1.795 |
Net margin | -3.05% | -3.84% | -2.38% | 16.93% | -4.86% | -3.74% |
EPS 2 | -0.1955 | -0.2461 | -0.1639 | 0.9833 | -0.2913 | -0.2599 |
Free Cash Flow 1 | -0.000625 | 0.6568 | 4.322 | -6.719 | -4.231 | -2.292 |
FCF margin | -0% | 1.44% | 9.04% | -16.51% | -10.23% | -4.78% |
FCF Conversion (EBITDA) | - | - | 385.57% | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/25/18 | 9/27/19 | 9/29/20 | 9/27/21 | 9/28/22 | 9/28/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 0.4 | 4.78 | 6.85 | 5.62 | 5.53 | 3.4 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0 | 0.66 | 4.32 | -6.72 | -4.23 | -2.29 |
ROE (net income / shareholders' equity) | -5.83% | -12.4% | -4.07% | 40.2% | -8.63% | -9.06% |
ROA (Net income/ Total Assets) | -4.05% | -5.4% | -0.78% | 3.93% | -18.7% | -5.67% |
Assets 1 | 39.31 | 32.49 | 145.2 | 175.4 | 10.71 | 31.67 |
Book Value Per Share 2 | 2.340 | 2.150 | 1.990 | 3.010 | 2.750 | 2.480 |
Cash Flow per Share 2 | 0.4700 | 1.110 | 1.620 | 1.440 | 0.9800 | 0.6400 |
Capex 1 | 1.86 | 1.27 | 1.19 | 2.6 | 3.19 | 2 |
Capex / Sales | 3.57% | 2.79% | 2.48% | 6.38% | 7.72% | 4.17% |
Announcement Date | 9/25/18 | 9/27/19 | 9/29/20 | 9/27/21 | 9/28/22 | 9/28/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-29.04% | 4.29M | |
-32.86% | 14.96B | |
-23.15% | 11.07B | |
+9.74% | 6.13B | |
-22.64% | 6.08B | |
-10.91% | 5.98B | |
+0.88% | 4.76B | |
+53.60% | 4.36B | |
-10.49% | 3.73B | |
-12.53% | 3.43B |
- Stock Market
- Equities
- SSY Stock
- Financials SunLink Health Systems, Inc.